According to Tongce Medical's announcement, on August 12, 2026, Baoqun Industrial, the controlling shareholder of the company, pledged 185.534.51 million shares, accounting for 12.24% of its shares and 4.15% of the total share capital, for use in medical projects outside the system; it released the pledge of 165.534.51 million shares, accounting for 10.92% of its shares and 3.70% of the total share capital. Baoqun Industrial has pledged a total of 101.086.72 million shares, accounting for 66.68% of its shares and 22.60% of its total share capital. The number of pledged shares due in the next six months and one year is 24.62 million shares and 602382.21 million shares, respectively. Baoqun Industrial has good credit and manageable pledge risks, and will not affect the company's control rights.

According to Tongce Medical's announcement, on August 12, 2026, Baoqun Industrial, the controlling shareholder of the company, pledged 185.534.51 million shares, accounting for 12.24% of its shares and 4.15% of the total share capital, for use in medical projects outside the system; it released the pledge of 165.534.51 million shares, accounting for 10.92% of its shares and 3.70% of the total share capital. Baoqun Industrial has pledged a total of 101.086.72 million shares, accounting for 66.68% of its shares and 22.60% of its total share capital. The number of pledged shares due in the next six months and one year is 24.62 million shares and 602382.21 million shares, respectively. Baoqun Industrial has good credit and manageable pledge risk, and will not affect the company's control.